Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut ...

Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...

For FY24, Kenvue reaffirms its outlook for net sales growth of 1% to 3% and adjusted earnings of $1.10 to $1.20 per share versus Street estimates for $1.14 in earnings on $15.65B in revenue.

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

Johnson & Johnson's former consumer unit, Kenvue Inc KVUE, reported its first quarterly earnings after being spun off in May.. Q2 sales increased 5.4% Y/Y to $4.01 billion, a Y/Y increase of 5.4% ...

Despite the earnings beat, Kenvue (NYSE:KVUE)’s stock dipped 0.9% following the release, suggesting a muted market reaction to the results. For the full year 2025, Kenvue now expects net sales ...

Kenvue Inc. (NYSE:KVUE) Q2 2023 Earnings Conference Call July 20, 2023 7:30 AM ETCompany ParticipantsTina Romani - Head, Investor RelationsThibaut Mongon - ...

Kenvue KVUE reported third-quarter earnings that were in line with our expectations. Total sales were up 3.3% year over year, largely thanks to price and mix, which contributed to 7.1% of total ...

Q1 revenue hit $3.74 billion vs. $3.68 billion consensus; sales down 3.9% YoY on lower volume and currency impact. Adjusted operating margin fell to 19.8% from 22.0% YoY 3 Summer "Power Patterns ...

Kenvue (KVUE) delivered earnings and revenue surprises of 14.29% and 1.75%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Kenvue (KVUE) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.32 per share a year ago. These figures ...